Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
Notes underwriting agrmnt
Inv. presentation
Quarterly results
Appointed COO
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/23/2020 GN Catalent et BrainStorm Cell Therapeutics annoncent un partenariat pour la conception de la plateforme de thérapie par cellules souches mésenchymateuses NurOwn®
10/23/2020 GN Catalent und BrainStorm Cell Therapeutics geben Partnerschaft zur Herstellung von NurOwn®, einer auf mesenchymalen Stammzellen beruhenden Therapie, bekannt
10/22/2020 GN Catalent and BrainStorm Cell Therapeutics Announce Partnership for the Manufacture of Mesenchymal Stem Cell Platform Therapy NurOwn®
05/07/2020 GN BrainStorm Announces Financial Results for the First Quarter of 2020 and Provides a Corporate Update
05/07/2020 GN BrainStorm Leases a New Cleanroom Facility at The Tel Aviv Sourasky Medical Center to Manufacture NurOwn® for The European Union
05/04/2020 GN BrainStorm Presents New Data Highlighting NurOwn® Immunomodulation in Neurology
04/29/2020 GN BrainStorm-Cell Therapeutics to Announce First Quarter Financial Results and Provide a Corporate Update
04/03/2020 GN BrainStorm Awarded $1.5 Million Non-Dilutive Grant for 2020 by the Israel Innovation Authority
04/01/2020 GN David Setboun Joins BrainStorm as Executive Vice President and Chief Operating Officer
03/31/2020 GN BrainStorm Appoints Renowned Distinguished Economist, Prof. Jacob Frenkel, Chairman of the Board of Directors
02/27/2020 GN Fifth and Final Site Announced for BrainStorm's Progressive Multiple Sclerosis Phase 2 Clinical Trial

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy